(Total Views: 443)
Posted On: 02/13/2021 10:58:07 AM
Post# of 148903
I don't think this article is unfair. There are lots of things to be excited about,which he touches on.
Our financing remains a challenge. Not uncommon for a pre revenue biotech.
We've all seen the volatility that occurs when Fife sells.
I'd our CD12 results are as we hope, our financing will resolve instantly.
Our financing remains a challenge. Not uncommon for a pre revenue biotech.
We've all seen the volatility that occurs when Fife sells.
I'd our CD12 results are as we hope, our financing will resolve instantly.
(4)
(0)Scroll down for more posts ▼
